Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia

Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia have?

Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia has 156 citations in the OpenAlex counts ScholarIQ stores.

When was Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia published?

Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia has 2015 year in the ScholarIQ index.

What is the open-access status of Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?

Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia has closed oa status in the ScholarIQ index.

What is the DOI of Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?

The DOI for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is on the source record.

What is the PMID of Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?

The PMID for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is on the source record.

What is the OpenAlex record for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?

The OpenAlex for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is on the source record.